ARQT vs PNW · rev $235.3M vs P/E 19, rev $2.61B
Arcutis Biotherapeutics Inc (ARQT) versus Pinnacle West Capital Corp (PNW) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
Latest reported PNW revenue for 2026-06-30 was $2.61B. Net income was $215.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
ARQT currently screens at market cap $1.64B. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Not investment advice. Open the ARQT and PNW stock pages for the full models.
Not investment advice.